Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Newer multiple sclerosis drugs and disability scores - are key data analyses missing?
Restoring nervous system structure and function using tissue engineered living scaffolds.
Pharmacodynamics and tolerability of repository corticotropin injection in healthy human subjects: A comparison with intravenous methylprednisolone.
[Support from a non-profit organisation to improve Multiple sclerosis patients' quality of life].
Mycophenolate mofetil in combination with interferon beta-1a in the treatment of relapsing-remitting multiple sclerosis: A preliminary study.
Switch-Associated Protein 70 Antibodies in Multiple Sclerosis: Possible Association with Disease Progression.
Multiple sclerosis: evaluation of purine nucleotide metabolism in central nervous system in association with serum levels of selected fat-soluble antioxidants.
Dimethyl fumarate (Tecfidera) for multiple sclerosis.
Cerebrospinal fluid apolipoprotein E and phospholipid transfer protein activity are reduced in multiple sclerosis; relationships with the brain MRI and CSF lipid variables.
How type I interferons work in multiple sclerosis and other diseases: some unexpected mechanisms.
Quantitative magnetic resonance imaging of cortical multiple sclerosis pathology.
TCR Transgenic Mice That Shed Light on Immune and Environmental Regulators in Multiple Sclerosis.
A Potential Alternative against Neurodegenerative Diseases: Phytodrugs.
Investigation-Directed Approach to Inflammatory Optic Neuropathies.
Neuropathologic, phenotypic and functional analyses of Mucosal Associated Invariant T cells in Multiple Sclerosis.
Ultrasound detection of knee joint degeneration in patients with multiple sclerosis.
MHC Class II Polymorphisms, Autoreactive T-Cells, and Autoimmunity.
Diabetes insipidus as a rare cause of acute cognitive impairment in multiple sclerosis.
Inhibitory effect of matrine on blood-brain barrier disruption for the treatment of experimental autoimmune encephalomyelitis.
Multiple sclerosis in Isfahan, Iran: an update.
Multiple sclerosis (MS) for the urologist: What should urologists know about MS?
Vitamin D Actions on CD4(+) T Cells in Autoimmune Disease.
Stepchild or Prodigy? Neuroprotection in Multiple Sclerosis (MS) Research.
A Longitudinal Examination of the Hopelessness Theory of Depression in People Who Have Multiple Sclerosis.
Endogenous adaptation to low oxygen modulates T-cell regulatory pathways in EAE.
Pages
« first
‹ previous
…
530
531
532
533
534
535
536
537
538
…
next ›
last »